Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKPD of Rocuronium During Kidney Transplantation
NCT02827435Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rocuronium in end stage renal disease (ESRD), sponsored by Seoul National University Hospital. Primary endpoints: Rocuronium plasma concentration at 120 months and Acceleromyography data (Train-of-Four ratio). Status: unknown.
02
Drugs
rocuronium
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02827435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02827435.